IMCI: The Next Cybersecurity Mover
Download Report in PDF Or Scroll down to read the complete report below.
INFINITE GROUP, INC.
The Next Major Cybersecurity Mover
March 7, 2022
INFINITE GROUP, INC. (OTCQB – IMCI - $0.124)
Price Target: $0.65
Headquartered in Pittsford, NY with a workforce spanning across the United States, IGI works with organizations on all levels of Information Security and Cybersecurity. IGI is also the OEM of the Nodeware® vulnerability management solution, an award-winning SaaS platform that continuously scans networks to identify critical vulnerabilities. Through the Company's evolution from 1986 to today, IGI has continued to build on its strong foundation of securing data, systems, and technologies to become a leader in the cybersecurity field.
A Four-Fold Share Price Jump in 4 Months? In our view, IMCI is on the cusp of a series of moves that could drive its stock toward our $0.65 price target during Q2. We present four factors that affirm this investment thesis.
Factor #1: The Cyber Landscape Plays to IMCI’s Strengths. Cyber vulnerabilities rank as the #1 concern for companies, including small businesses, as noted in a recent Allianz Risk Barometer update. According to Accenture’s Cost of Cybercrime Study, 43% of cyber attacks target small businesses, yet only 14% are prepared for them. This scenario should drive deployment of IMCI’s SaaS-based Nodeware® in 2022 and 2023.
Factor #2: Pending Acquisition to Add Revenue, Customers, Profit. In February, IMCI, as part of its mentioned strategic roll-up strategy, announced its plans to acquire Pratum, Inc. Pratum could add $4M+ in annual revenue and a large customer base , as well as complementary services and products. The deal is slated to close in 2Q22.
Factor #3: Even at Our Target Price, IMCI Would Be Cheap. Pubco peer valuations and M&A activity price/revenue multiples illustrate a 10.2x multiple on 2022E sales. Using $11M in revenue as a no growth figure, reaching $0.65 would assume an 80% industry multiple discount. Given the expectation of meaningful sales growth, the discount should narrow considerably, making $0.65 a potentially conservative expectation.
Factor #4: Upcoming Milestones Abound. M&A closing, cross-sales, potential NASDAQ uplist could serve as major share price appreciation catalysts.
IMCI’s Core Business is Well-Positioned
As noted above, Accenture’s Cost of Cybercrime Study notes that 43% of cyber attacks in 2021 targeted small businesses, yet only 14% are prepared to defend them. By utilizing targeted services and affordable SaaS-based platforms, the aforementioned outliers that have not yet employed cybersecurity tools can adopt IMCI’s diverse and market sized offerings. This scenario should drive deployment of IMCI’s SaaS-based Nodeware® in 2022 and 2023, as well as a series of recurring services. IMCI sells its cybersecurity software and services through channel partners, which include direct channel partners, Telarus, SYNNEX, and Staples, and through their direct cybersecurity services teams. Cybersecurity services include Chief Information Security Team as a Service (CISOTaaS™), penetration testing services (PenLogic™), security assessments, incident response and others, and are provided through channel partners and direct to end customers.
While we are waiting for IMCI’s 10-K to be filed, we believe the figures will confirm a rising contribution of Nodeware® and cyber-specific services/solutions to overall revenue. Clearly management is anticipating a meaningful increase in sales in 2022/2023 from its own efforts and via acquisition, as IMCI has dramatically built up its sales and managerial team over the past few quarters.
Pending Acquisition Elevates IMCI’s Status
IMCI has a long history in the information security industry. The growing deployment of cutting-edge Nodeware®, its SaaS-based vulnerability management platform that targets small-medium sized enterprises, fosters more profitable SaaS-based and other solutions for the Company going forward. Interestingly, the pending Pratum acquisition serves as a favorable complement to IMCI’s overall business and opens the door for considerable cross-sale opportunities.
As part of a strategic roll-up strategy identifying other cybersecurity companies to acquire, IMCI has put its first forward by announcing the definitive agreement to acquire Pratum, Inc. Pratum is an information security services firm founded in 2008 that helps guide organizations in IT risk management, and compliance. With approximately $4.3 million in annual sales, Pratum provides cybersecurity consulting services, security assessments, and SOC/XDR services, which is a strategic fit for IGI. Importantly, Pratum serves an expansive client portfolio that includes clients nationwide and overseas, ranging from small businesses to multinational corporations across industries. Together, IMCI and Pratum can offer best-in-class software and services to a broad base of clients nationwide. The deal is slated to close in 2Q22.
Valuation, Price Target, Upcoming Events
A review of 2021 M&A transactions and publicly traded peers (see Table I) and their current valuations on a price/revenue multiple basis illustrate a roughly 10x multiple on 2022E sales. Using $11M in revenue as a no growth figure for IMCI in 2022 (just as an example), reaching $0.65 would assume a more than 80% discount to the peer group’s price/revenue multiple. With a series of upcoming milestone events, including the aforementioned pending acquisition, a potential up-list to NASDAQ, and the expectation of meaningful sales growth, the discount should narrow considerably, making $0.65 a potentially conservative expectation. Once the 10-K is filed we plan to perform a more in-depth review of IMCI and its outlook for 2022 and beyond.
Senior Analyst: Robert Goldman
Rob Goldman founded Goldman Small Cap Research in 2009 and has over 25 years of investment and company research experience as a senior research analyst and as a portfolio and mutual fund manager. During his tenure as a sell side analyst, Rob was a senior member of Piper Jaffray's Technology and Communications teams. Prior to joining Piper, Rob led Josephthal & Co.'s Washington-based Emerging Growth Research Group. In addition to his sell-side experience Rob served as Chief Investment Officer of a boutique investment management firm and Blue and White Investment Management, where he managed Small Cap Growth portfolios and The Blue and White Fund.
I, Robert Goldman, hereby certify that the view expressed in this research report accurately reflect my personal views about the subject securities and issuers. I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the recommendations or views expressed in this research report.
This Opportunity Research report was prepared for informational purposes only.
Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research and Goldman Opportunity Research. The Select format reflects the Firm’s internally generated stock ideas along with economic and stock market outlooks. Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored micro-cap research ideas that typically carry greater risks than those stocks covered in the Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Research reports on profiled stocks in the Opportunity Research format typically have a higher risk profile and may offer greater upside. Goldman Small Cap Research (GSCR) was compensated by the Company in the amount of $4500 for a research report production, an update, and press releases. GSCR was compensated $1500 for the production of this update and a press release. All information contained in this report was provided by the Company via filings, press releases or its website, or through our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
Separate from the factual content of our articles about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report or note is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This report does not take into account the investment objectives, financial situation, or particular needs of any particular person. This report does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA, the U.S. Securities and Exchange Commission or with any state securities regulatory authority.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com